NCT02596282

Brief Summary

Background: Medical male circumcision (MMC) for HIV prevention is a priority in 14 East and Southern African countries, and the long-term sustainability of MMC programs could best be achieved by early infant male circumcision (EIMC.) However, the acceptability and safety of EIMC provided by non-physicians is unknown. Methods: We conducted a trial of EIMC using the Mogen clamp provided by newly trained clinical officers (CO) and nurse midwives (NMWs) in 4 health centers in rural Rakai, Uganda. 501 healthy neonates aged 1-28 days with normal birth weight and gestational age were randomized to CO (n=256) and NMWs (n=245), and were followed up at 24 hours, 7 and 28 days. Combined analgesia was provided by paracetamol suppository, Eutectic Mixture of Local Anesthetics (EMLA) cream and a 24% sucrose solution.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
501

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Oct 2014

Shorter than P25 for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2015

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 4, 2015

Completed
Last Updated

November 4, 2015

Status Verified

November 1, 2015

Enrollment Period

9 months

First QC Date

October 23, 2015

Last Update Submit

November 2, 2015

Conditions

Keywords

neonatal male circumcisionClinical officers vs Nurse midwivesRakai, Ugandaacceptability and safety of neonatal male circumcision

Outcome Measures

Primary Outcomes (3)

  • Adverse events related to circumcision

    Adverse events graded as mild, moderate and severe

    4 weeks

  • Acceptability as measured by the proportion of mothers directly informed about the study who consented to enroll in the trial

    Proportion of registered mother-child pairs in which the male infant was circumcised

    through study completion, an of 1 year

  • Wound healing

    Completed wound healing (clean intact scar without a scab or stitch sinus)

    4 weeks

Secondary Outcomes (3)

  • Procedure time

    Less than 15 minutes

  • Parental satisfaction

    4 weeks

  • Neonatal pain scale (NIPS)

    During surgery

Study Arms (2)

Clinical Officer (CO),

ACTIVE COMPARATOR

COs were trained and provided neonatal male circumcision under topical anesthesia using the Mogen clamp

Procedure: Neonatal circumcision under topical anesthesia

Nurse Midwife (NMW)

EXPERIMENTAL

NMWs were trained and provided neonatal male circumcision under topical anesthesia using the Mogen clamp

Procedure: Neonatal circumcision under topical anesthesia

Interventions

The standard procedure for neonatal circumcision is as follows: combined analgesia was topical 2.5% lidocaine and 2.5% prilocaine \<1 gm applied 60 minutes and 40mg acetaminophen suppository 30 minutes prior to surgery. Infants were given a 24% sucrose solution pacifier if needed. Infants under 2 weeks of age received subcutaneous Vitamin K 1 mg. The perineum cleaned, and the penis swabbed with povidone iodine. Hemostats were applied at 3 and 9 o'clock positions and the glans pushed down. Traction was applied before placing the Mogen clamp, the clamp was closed for 5 minutes and the foreskin removed with a scalpel. Petroleum jelly (e.g., Vaseline) was applied to the glans and the wound covered with sterile gauze. Infants were observed for one hour. Mothers were instructed in wound care.

Also known as: Mogen clamp, Pre-operative analgesia
Clinical Officer (CO),Nurse Midwife (NMW)

Eligibility Criteria

Age1 Day - 28 Days
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • age 1-28 days
  • birth weight \>= 2,500 gm
  • gestational age \>=37 weeks
  • no illness. normal temperature
  • no genital anatomic abnormality

You may not qualify if:

  • age \>28 days
  • birth weight \<2,500 gm
  • gestational age \<37 weeks
  • Ill health
  • genital abnormality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Kankaka EN, Murungi T, Kigozi G, Makumbi F, Nabukalu D, Watya S, Kighoma N, Nampijja R, Kayiwa D, Nalugoda F, Serwadda D, Wawer M, Gray RH. Randomised trial of early infant circumcision performed by clinical officers and registered nurse midwives using the Mogen clamp in Rakai, Uganda. BJU Int. 2017 Jan;119(1):164-170. doi: 10.1111/bju.13589. Epub 2016 Sep 6.

Study Officials

  • Ronald H Gray, MD MSc

    Johns Hopkins Bloomberg School of Public Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 23, 2015

First Posted

November 4, 2015

Study Start

October 1, 2014

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

November 4, 2015

Record last verified: 2015-11